Dr. Lal Pathlabs Q4 PAT seen up 26.2% YoY to Rs. 50.6 cr: Prabhudas Lilladher

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Dr. Lal Pathlabs to report net profit at Rs. 50.6 crore up 26.2% year-on-year (up 10.5% quarter-on-quarter).

Net Sales are expected to increase by 30.2 percent Y-o-Y (up 18.8 percent Q-o-Q) to Rs. 347.4 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 19.2 percent Y-o-Y (up 16.3 percent Q-o-Q) to Rs. 76.3 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More